News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Morenstein Scott D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $15.43, valued at
$231.5k
|
|
| 11/25/2019 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Bought 468,750 shares
@ $8, valued at
$3.8M
|
|
| 05/30/2019 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $8.21, valued at
$123.2k
|
|
| 12/28/2018 |
4
| CDK ASSOCIATES, L.L.C. (Director) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Bought 25,000 shares
@ $3.45, valued at
$86.3k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2018 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $6.31, valued at
$94.7k
|
|
| 10/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2016 |
4
| Morenstein Scott D (Director) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP|
Txns:
| Granted 17,857 shares
@ $0 |
|
| 12/07/2015 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Bought 5,000 shares
@ $1.865, valued at
$9.3k
|
|
| 11/05/2015 |
4
| Morenstein Scott D (Director) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP|
Txns:
| Granted 40,000 options to buy
@ $0.67, valued at
$26.8k
|
|
| 06/15/2015 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 14,000 options to buy
@ $2.6, valued at
$36.4k
|
|
| 06/16/2014 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 14,000 options to buy
@ $2.8, valued at
$39.2k
|
|
| 02/12/2014 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed of 1,669,138 shares
@ $0
Disposed of 95,945 shares
@ $0
Acquired 1,123,612 shares
@ $0
Acquired 1,277 shares
@ $0
Disposed of 467,358 warrants
@ $3.58, valued at
$1.7M
Disposed of 26,864 warrants
@ $3.58, valued at
$96.2k
Acquired 314,611 warrants
@ $3.58, valued at
$1.1M
Acquired 358 warrants
@ $3.58, valued at
$1.3k
|
|
| 06/04/2013 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 28,000 options to buy
@ $3.116, valued at
$87.2k
|
|
|
|